• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

疫情期间加利福尼亚州新冠肺炎住院患者的用药模式

Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.

作者信息

Watanabe Jonathan H, Kwon Jimmy, Nan Bin, Abeles Shira R, Jia Stanley, Mehta Sanjay R

机构信息

Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine.

Department of Statistics, University of California, Irvine Donald Bren School of Information and Computer Sciences, Irvine.

出版信息

JAMA Netw Open. 2021 May 3;4(5):e2110775. doi: 10.1001/jamanetworkopen.2021.10775.

DOI:10.1001/jamanetworkopen.2021.10775
PMID:34019090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8140369/
Abstract

This cohort study examines trends in medication use among patients hospitalized for COVID-19–related treatment in a large US university health care system from the start of stay-at-home orders in March 2020 throughout the rest of the year.

摘要

这项队列研究调查了2020年3月居家令开始至当年剩余时间里，在美国一家大型大学医疗系统中因新冠病毒疾病相关治疗而住院的患者的用药趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b89/8140369/e62ab53158d0/jamanetwopen-e2110775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b89/8140369/20883a331010/jamanetwopen-e2110775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b89/8140369/e62ab53158d0/jamanetwopen-e2110775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b89/8140369/20883a331010/jamanetwopen-e2110775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b89/8140369/e62ab53158d0/jamanetwopen-e2110775-g002.jpg

相似文献

1
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.疫情期间加利福尼亚州新冠肺炎住院患者的用药模式
JAMA Netw Open. 2021 May 3;4(5):e2110775. doi: 10.1001/jamanetworkopen.2021.10775.
2
Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.新冠肺炎住院患者中的肺炎链球菌合并感染
Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1353-1355. doi: 10.1007/s10096-021-04166-w. Epub 2021 Jan 19.
3
Some drugs for COVID-19.一些用于治疗新冠肺炎的药物。
Med Lett Drugs Ther. 2020 Apr 6;62(1595):49-50.
4
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
5
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.羟氯喹、瑞德西韦和地塞米松在美国 COVID-19 住院成人患者中的使用：一项回顾性队列研究。
Ann Intern Med. 2021 Oct;174(10):1395-1403. doi: 10.7326/M21-0857. Epub 2021 Aug 17.
6
Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement.美国 COVID-19 住院患者及肺部受累患者的治疗模式。
J Med Virol. 2021 Sep;93(9):5367-5375. doi: 10.1002/jmv.27049. Epub 2021 May 31.
7
Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region.低负担地区住院 COVID-19 患者的临床特征和结局。
Pathog Glob Health. 2021 Jun;115(4):243-249. doi: 10.1080/20477724.2021.1893485. Epub 2021 Feb 28.
8
Psychopharmacology of COVID-19.新型冠状病毒肺炎的精神药理学。
Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18.
9
COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.大型多机构医疗系统中COVID-19的治疗组合及其与死亡率的关联
PLoS One. 2021 Jun 11;16(6):e0252591. doi: 10.1371/journal.pone.0252591. eCollection 2021.
10
Possible treatment and strategies for COVID-19: review and assessment.针对 COVID-19 的可能治疗方法和策略：综述与评估。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12593-12608. doi: 10.26355/eurrev_202012_24057.

引用本文的文献

1
Drug utilisation patterns & clinical outcomes in hospitalised COVID-19 patients: A geospatial & machine learning approach.住院COVID-19患者的药物使用模式及临床结局：一种地理空间与机器学习方法。
Indian J Med Res. 2025 Apr;161(4):375-385. doi: 10.25259/IJMR_352_24.
2
Adherence of Physicians to Local Guideline Recommendations among Patients with COVID-19 in Two Tertiary Public Hospitals in Metro Manila, Philippines: A Rapid Assessment Study.菲律宾马尼拉大都会两家三级公立医院中医生对新冠肺炎患者当地指南建议的遵循情况：一项快速评估研究
Acta Med Philipp. 2023 Nov 24;57(11):34-40. doi: 10.47895/amp.vi0.6256. eCollection 2023.
3

本文引用的文献

1
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
2
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.新型冠状病毒肺炎患者静脉血栓栓塞症的预防、诊断和治疗：CHEST 指南和专家报告。
Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Assessment of Medication Prescribing Pattern in COVID-19 Admitted Patients by Using WHO Prescribing Indicators at Eka Kotebe General Hospital, Addis Ababa, Ethiopia; Retrospective Cross-Sectional Study.
在埃塞俄比亚亚的斯亚贝巴埃卡科泰贝综合医院，采用世界卫生组织处方指标评估新冠肺炎住院患者的用药处方模式；回顾性横断面研究。
Drug Healthc Patient Saf. 2023 Nov 3;15:171-177. doi: 10.2147/DHPS.S416310. eCollection 2023.
4
Risk Factors for the Prescription of Ineffective Antiviral Candidates for COVID-19 During the Early Pandemic Period in Korea.韩国大流行早期 COVID-19 无效抗病毒候选药物处方的风险因素。
J Korean Med Sci. 2023 Sep 11;38(36):e280. doi: 10.3346/jkms.2023.38.e280.
5
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022.2021年1月至2022年2月美国2019冠状病毒病住院患者药物使用模式的描述性队列研究。
Open Forum Infect Dis. 2023 Jul 10;10(7):ofad339. doi: 10.1093/ofid/ofad339. eCollection 2023 Jul.
6
The Japanese Guide affected the prescription of steroids for COVID-19 inpatients during the COVID-19 epidemic in Japan.日本指南在日本 COVID-19 疫情期间影响了 COVID-19 住院患者的类固醇处方。
Sci Rep. 2023 Jun 3;13(1):9041. doi: 10.1038/s41598-023-36199-w.
7
Clinical Disease Characteristics and Treatment Trajectories Associated with Mortality among COVID-19 Patients in Punjab, Pakistan.巴基斯坦旁遮普省新冠肺炎患者的临床疾病特征及与死亡率相关的治疗轨迹
Healthcare (Basel). 2023 Apr 21;11(8):1192. doi: 10.3390/healthcare11081192.
8
Characterization of COVID-19 Hospitalized Patients in Three United States Electronic Health Record Databases.美国三个电子健康记录数据库中新冠病毒肺炎住院患者的特征分析
Pathogens. 2023 Mar 1;12(3):390. doi: 10.3390/pathogens12030390.
9
Prescription Patterns of Drugs Given to Hospitalized COVID-19 Patients: A Cross-Sectional Study in Colombia.给予住院COVID-19患者的药物处方模式：哥伦比亚的一项横断面研究
Antibiotics (Basel). 2022 Mar 3;11(3):333. doi: 10.3390/antibiotics11030333.
10
[Enoxaparin dose associated with decreased risk of death in COVID-19].[与降低COVID-19死亡风险相关的依诺肝素剂量]
Rev Med Inst Mex Seguro Soc. 2022 Feb 1;60(1):33-39.
羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.